Clinical trial
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for…
NCT00004327 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004327 |
|---|---|
| Title | Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Yale University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hereditary Hemorrhagic Telangiectasia, Ectasia |
| Intervention type | Drug |
| Interventions | octreotide |
| Enrollment | 8 |
| Start date | Jan 1, 1995 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: